Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
Br J Cancer. 2018 Mar 20;118(6):e14.
doi: 10.1038/bjc.2018.4.
Epub 2018 Feb 20.